Evidence map›Paper›PMID 39118171›Full record

ReviewBiological research2024

Enhancing adipose tissue functionality in obesity: senotherapeutics, autophagy and cellular senescence as a target.

Consuelo Arias, Javiera Álvarez-Indo, Mariana Cifuentes, Eugenia Morselli, Bredford Kerr, Patricia V Burgos

Abstract readReview
In one paragraph

Review in Biological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Effect ofInternational journal of endocrinology · 2026
    Article
  3. Article
  4. Prenatal Exposure to PMEnvironment & health (Washington, D.C.) · 2025
    Article
  5. Review
  6. Review
  7. Food science & nutrition · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Consuelo AriasEscuela de Kinesiología, Facultad de Odontología y Ciencias de la Rehabilitación, Universidad San Sebastián, Santiago, 7500922, Chile. consuelo.arias@uss.cl.
Javiera Álvarez-IndoCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile.
Mariana CifuentesInstitute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile.
Eugenia MorselliDepartment of Basic Sciences, Faculty of Medicine and Sciences, Universidad San Sebastián, Santiago, Chile.
Bredford KerrCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile.
Patricia V BurgosCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile. patricia.burgos@uss.cl.ORCID http://orcid.org/0000-0003-4521-7978

Funding

ANID/BASAL FB210008ANID/FONDAP 1523A0008Anillo ACT210039FONDECYT 1211261FONDECYT 1211477FONDECYT 1230905FONDECYT 1240623UVERSIDAD SAN SEBASTIAN VRID-FAPPE22/05
6 · The paper itself

Abstract

Obesity, a global health crisis, disrupts multiple systemic processes, contributing to a cascade of metabolic dysfunctions by promoting the pathological expansion of visceral adipose tissue (VAT). This expansion is characterized by impaired differentiation of pre-adipocytes and an increase in senescent cells, leading to a pro-inflammatory state and exacerbated oxidative stress. Particularly, the senescence-associated secretory phenotype (SASP) and adipose tissue hypoxia further impair cellular function, promoting chronic disease development. This review delves into the potential of autophagy modulation and the therapeutic application of senolytics and senomorphics as novel strategies to mitigate adipose tissue senescence. By exploring the intricate mechanisms underlying adipocyte dysfunction and the emerging role of natural compounds in senescence modulation, we underscore the promising horizon of senotherapeutics in restoring adipose health. This approach not only offers a pathway to combat the metabolic complications of obesity, but also opens new avenues for enhancing life quality and managing the global burden of obesity-related conditions. Our analysis aims to bridge the gap between current scientific progress and clinical application, offering new perspectives on preventing and treating obesity-induced adipose dysfunction.

Indexed as

Adipose TissueAutophagyCellular SenescenceObesitySenotherapeuticsAdipocytesAnimalsHumansSenotherapeutics

Identifiers

PMID39118171
PMCPMC11312694

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.